Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-10
1997-08-26
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548183, A61K 31425
Patent
active
056611684
ABSTRACT:
Provided is a method for treating hyperglycemia utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant method are novel and, accordingly, such compounds and pharmaceutical formulations thereof, are also provided.
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4376777 (1983-03-01), Kawamatsu et al.
patent: 4387101 (1983-06-01), Kawamatsu et al.
patent: 4461902 (1984-07-01), Kawamatsu et al.
patent: 4464382 (1984-08-01), Tanouchi et al.
patent: 4552891 (1985-11-01), Ho et al.
patent: 4617312 (1986-10-01), Schnur
patent: 4636516 (1987-01-01), Kubo et al.
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4863923 (1989-09-01), Ho et al.
patent: 4948900 (1990-08-01), Iijima et al.
patent: 4971996 (1990-11-01), Shiraishi et al.
patent: 4997948 (1991-03-01), Zask et al.
patent: 5116855 (1992-05-01), Inoui et al.
patent: 5158966 (1992-10-01), Lafferty
patent: 5223522 (1993-06-01), Clark
patent: 5236941 (1993-08-01), Zask
patent: 5260445 (1993-11-01), Hindley
patent: 5330998 (1994-07-01), Clark
patent: 5330999 (1994-07-01), Nanteuil
patent: 5506745 (1996-04-01), Regnier
patent: 5523314 (1996-06-01), Buc-Valleskey
U.S. application No. 07/660,328, Panetta et al., filed Feb. 22, 1991.
Teuber et al., Liebigs Ann.Chem., 757 (1978).
Katsumi et al., Chem.Pharm.Bull., 34(4) 1619 (1986).
Chakrabarti et al., Tetrahedron, 2781 (1969).
Roggero et al., Bull. De La Societe Chimique De France 11, 4021 (1971).
Patent Abstracts of Japan, 11(232) (C-437) [2679] 1987, abstracting JP 62-45553.
Allan et al., J.Org. Chem., 23, 112 (1958).
Fujita et al., Diabetes 32, 804 (1983).
Shoda et al., Chem.Pharm.Bull, 30(10), 3563 (1982).
Shoda et al., Chem.Pharm.Bull., 30(10), 3580 (1982).
Shoda et al., Chem.Pharm.Bull., 32(6), 2267 (1984).
Tomisawa et al., Chem.Pharm.Bull., 34(2), 701 (1986).
Isomura et al., Chem.Pharm.Bull., 32(1), 152 (1984).
Patent Abstracts of Japan, 11(206) (C-433) [2653] 1987, abstracting JP 62-29570.
Derwent Abstracts, 87-076383/11, abstracting J6 2029-579A (1987).
Chemical Abstracts, vol. 116, No. 20983q (1992).
Chemical Abstracts, 69, No. 42531d (1968).
Agarwal, et al., Curr. Sci., 49712) 455 (1980).
Husain, et al., Acta Pharma. Jugoslav., 36(3) 311 (1986).
Derwent Abstracts 91-031957, abstracting JP-A-2 300, 119 (1991).
Mohan et al., Indian Drugs, 21/3, 90 (1983).
Bue-Valleskey Juliana
Hunden David C.
Jones Charles D.
Panetta Jill A.
Shaw Walter N.
Eli Lilly and Company
Gerstl Robert
Palmberg Arleen
LandOfFree
Hypoglycemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988824